Stay informed with the latest updates for the inheritable blood disorders community.

Industry
Ipsen and Inspiration Partner to Produce Recombinant Factor Therapies
Blood Safety
FDA's vCJD Assessment Model Shows Increased Risk
Advocacy & Legislative
Federal Advocacy Update
Advocacy & Legislative
Government Issues Ryan White Report
Medical
Study Shows Benefits of Prophylaxis in Children with Hemophilia B
Medical Advisory
Medical Advisory #410: FDA Issues Recall of Huber Needles and Huber…
Advocacy & Legislative
Updated Analysis of Health Reform Bills Available
Medical
New HCV Therapy Shows Promise in Early Trials
Medical
FDA Approves New von Willebrand Disease Product
Medical
Vigorous Athletic Activity May Not Harm Children with Hemophilia
Medical Advisory
Medical…
Medical Advisory
Medical Advisory #408: CSL…
Medical Advisory
Medical Advisory #407: CSL Behring Initiates Voluntary…
Medical Advisory
Medical Advisory #406: FDA Confirms Low Risk for Creutzfeldt-Jakob Disease…
Medical Advisory
Medical Advisory #405: Novo Nordisk Issues Missing Product Alert